India vows action if cough syrup proved to be behind Gambia deaths | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
June 12, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JUNE 12, 2025
India vows action if cough syrup proved to be behind Gambia deaths

South Asia

Reuters
06 October, 2022, 08:05 pm
Last modified: 06 October, 2022, 08:04 pm

Related News

  • WHO warns of falsified cough syrup ingredients seized in Pakistan
  • India firm denies tampering with tests in probe of cough syrup deaths
  • Indonesian court papers reveal chain of events that led to cough syrup deaths
  • Indian firms linked to cough syrup deaths had received warnings
  • Uzbekistan starts trial over 65 child deaths linked to contaminated cough syrups

India vows action if cough syrup proved to be behind Gambia deaths

Reuters
06 October, 2022, 08:05 pm
Last modified: 06 October, 2022, 08:04 pm
The four medicines are cough and cold syrups produced in India, said the WHO statement.(Picture courtesy: Shutterstock)
The four medicines are cough and cold syrups produced in India, said the WHO statement.(Picture courtesy: Shutterstock)

Summary

  • Cough syrup made by India's Maiden Pharma linked to 66 deaths
  • Maiden says trying to find out from Gambia buyer what happened
  • Maiden says not selling any product in India currently
  • India health ministry seeks details from WHO
  • India health ministry vows to take "all required steps"

India is testing samples of cough syrups produced by Maiden Pharmaceuticals after the World Health Organization said its products were linked to the deaths of dozens of children in Gambia, a government official said on Thursday.

The deaths of 66 children in the West African country is a blow to India's image as a "pharmacy of the world" that supplies medicines to all continents, especially Africa. The cough syrup was made by New Delhi-based Maiden Pharmaceuticals, the WHO said.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Gambia urgently recalls India-made cough syrups blamed for 66 child deaths

"Samples have been sent to a central pharmaceutical laboratory for testing," Anil Vij, the health minister of Haryana state where Maiden has its factories, told reporters. "Strict action will be taken if anything is found wrong."

The federal health ministry would take all "required steps" in the matter, two officials said, adding that India was awaiting a report establishing "causal relation to death with the medical products in question" from the WHO.

Naresh Kumar Goyal, a Maiden director, told Reuters it heard about the deaths only on Thursday morning and were trying to find out details.

"We are trying to find out the situation because it cropped up only today," he said by phone. "We are trying to find out with the buyer and all that what has happened exactly. We are not selling anything in India."

He declined to speak further.

WHO Director-General Tedros Adhanom Ghebreyesus told reporters on Wednesday that the U.N. agency was investigating the deaths from acute kidney injuries with India's drug regulator and the drug maker.

The agency informed the Drugs Controller General of India of the deaths late last month after which the regulator launched an investigation with state authorities, in tandem with the WHO, the two India health ministry sources said.

The ministry has not issued a statement.

The WHO said laboratory analysis of Maiden cough syrup had confirmed "unacceptable" amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury.

Maiden, which launched its operations in November 1990, manufactured and exported the syrup only to Gambia, the Indian ministry sources said. Maiden says on its website it has two manufacturing plants, in Kundli and Panipat, both near New Delhi in Haryana, and has recently set up another one.

It has an annual production capacity of 2.2 million syrup bottles, 600 million capsules, 18 million injections, 300,000 ointment tubes and 1.2 billion tablets.

Maiden says on its website it sells its products at home and exports to countries in Asia, Africa and Latin America, though Goyal said they were not currently selling in India.

The two health ministry sources said that importing countries typically test such products before allowing their use.

The WHO said the Maiden products - Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup - may have been distributed elsewhere through informal markets but it had only been identified in Gambia.

World+Biz

India-made cough syrups / cough syrup

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Home Affairs Adviser Lieutenant General (Retd.) Jahangir Alam Chowdhury speaks to journalists in Salna, Gazipur, on 12 June 2025. Photo: TBS
    No bar to Tarique Rahman returning to Bangladesh: Home adviser
  • Bangladesh Bank Governor Ahsan H Mansur. TBS Sketch
    Bangladesh considers settlements with tycoons over offshore wealth: Mansur tells FT
  • Chief Adviser Muhammad Yunus and BNP Acting Chairman Tarique Rahman. Photos: Collected
    Tarique may propose election in first week of February in meeting with CA

MOST VIEWED

  • File photo of ex-prime minister Sheikh Hasina and her son Sajeeb Wazed Joy. Photo: Collected
    Joy spends Eid with Hasina in India: Indian media
  • Infofgraphics: TBS
    DGHS issues 11-point directive to prevent spread of Covid-19 in Bangladesh
  • Saifuzzaman Chowdhury. Photo: Collected
    UK crime agency now freezes assets of ex-land minister Saifuzzaman: AJ
  • File photo of BNP Standing Committee Member Amir Khasru Mahmud Chowdhury. Photo: Collected
    Khasru flies to London ahead of Yunus-Tarique meeting
  • Chief Adviser Muhammad Yunus speaks at the Chatham House in London on 11 June 2025. Photo: CA Press Wing
    No desire to be part of next elected govt: CA Yunus
  • Illustration: Khandaker Abidur Rahman/TBS
    Three hospitals ‘held hostage’ as discharged July uprising injured keep occupying beds

Related News

  • WHO warns of falsified cough syrup ingredients seized in Pakistan
  • India firm denies tampering with tests in probe of cough syrup deaths
  • Indonesian court papers reveal chain of events that led to cough syrup deaths
  • Indian firms linked to cough syrup deaths had received warnings
  • Uzbekistan starts trial over 65 child deaths linked to contaminated cough syrups

Features

Among pet birds in the country, lovebirds are the most common, and they are also the most numerous in the haat. Photo: Junayet Rashel

Where feathers meet fortune: How a small pigeon stall became Dhaka’s premiere bird market

19h | Panorama
Illustration: Duniya Jahan/ TBS

Forget Katy Perry, here’s Bangladesh’s Ruthba Yasmin shooting for the moon

1d | Features
File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar

Dhaka: The city we never want to return to, but always do

3d | Features
Photo collage shows political posters in Bagerhat. Photos: Jannatul Naym Pieal

From Sheikh Dynasty to sibling rivalry: Bagerhat signals a turning tide in local politics

4d | Bangladesh

More Videos from TBS

Delhi on Boil: Red Alert as Temperatures Soar

Delhi on Boil: Red Alert as Temperatures Soar

40m | TBS Stories
UK Prime Minister Keir Starmer did not respond to a request to meet with Dr. Muhammad Yunus

UK Prime Minister Keir Starmer did not respond to a request to meet with Dr. Muhammad Yunus

1h | TBS World
My words have been misinterpreted: Shafiqul Alam

My words have been misinterpreted: Shafiqul Alam

2h | TBS Stories
What did the Chief Advisor do on the second day of his UK visit?

What did the Chief Advisor do on the second day of his UK visit?

2h | TBS Stories
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net